---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-289829"
form_type: "8-K"
ticker: "CUE"
cik: "0001645460"
company_name: "Cue Biopharma, Inc."
filed_at: "2021-10-01T23:59:59+00:00"
generated_at: "2026-06-28T23:59:25.600113+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Cue Biopharma enters $80M at-the-market equity offering agreement with Jefferies

## Summary
- Company enters Open Market Sale Agreement with Jefferies LLC to sell up to $80M of common stock at-the-market.
- Prior $40M ATM agreement with Stifel terminated; $33.4M in gross proceeds realized from 2,099,700 shares sold.
- Jefferies will receive 3.0% commission on gross proceeds from sales under the new agreement.
- Shares will be sold under existing shelf registration statement; prospectus supplement filed.

## SEC filing metadata
- accession: 0001193125-21-289829
- form_type: 8-K
- ticker: CUE
- cik: 0001645460
- company_name: Cue Biopharma, Inc.
- filed_at: 2021-10-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1645460/000119312521289829/0001193125-21-289829-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1645460/000119312521289829/d197369d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-289829
- JSON: https://secwatch.observer/filing/0001193125-21-289829.json
- Plain text: https://secwatch.observer/filing/0001193125-21-289829.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.